Nghiên cứu tổng hợp vi hạt chitosan tải glucosamine bằng kỹ thuật phun điện đồng trục
Abstract
Glucosamine-loaded chitosan (GA@CS) microparticles were synthesized via coaxial electrospraying to develop an oral drug delivery system capable of protecting the active ingredient in the gastric environment and enhancing its release within the intestinal media. Optimal parameters included an applied voltage of 19 kV, a spraying distance of 5 cm, core/shell flow rates of 0.15/0.2 mL/h, a GA/CS volume ratio of 20% in the core, and core/shell solution concentrations of 4%. SEM analysis combined with ImageJ revealed relatively uniform, spherical microparticles. Encapsulation and loading efficiencies reached 57.15% and 24.49%, respectively, as determined by UV-Vis spectroscopy based on the Elson-Morgan/DMAB reaction. Release studies conducted at pH 1.2, 6.8, and 7.4 demonstrated that the GA@CS system exhibits pH-dependent release characteristics; it showed controlled release in an acidic environment and sustained release at pH 6.8 and pH 7.4 over 24 hours. These results confirm the potential of the GA@CS system for protecting the active ingredient and controlling oral drug release, paving the way for applications in the supportive treatment of musculoskeletal disorders.
Tóm tắt
Vi hạt chitosan tải glucosamine (GA@CS) được tổng hợp bằng phương pháp phun điện đồng trục nhằm phát triển hệ mang thuốc đường uống có khả năng bảo vệ dược chất trong môi trường dạ dày và tăng giải phóng tại môi trường đường ruột. Thông số tối ưu gồm hiệu điện thế 19 kV, khoảng cách phun 5 cm, lưu lượng lõi/vỏ 0,15/0,2 mL/h, tỷ lệ thể tích GA/CS trong lõi 20%, nồng độ dung dịch lõi/vỏ đều 4%. Phân tích SEM kết hợp ImageJ cho thấy vi hạt có hình cầu đồng đều. Hiệu suất bao gói đạt 57,15% và hiệu suất tải đạt 24,49% được xác định bằng UV-Vis dựa trên phản ứng Elson-Morgan/DMAB. Việc thử nghiệm giải phóng tại pH 1,2; 6,8 và 7,4 cho thấy hệ GA@CS có đặc tính giải phóng phụ thuộc pH. Hệ có khả năng kiểm soát giải phóng trong môi trường acid và duy trì giải phóng bền vững tại pH 6,8 và pH 7,4 sau 24 giờ. Kết quả khẳng định tiềm năng của GA@CS trong bảo vệ dược chất và kiểm soát giải phóng đường uống, hướng đến ứng dụng hỗ trợ điều trị bệnh lý xương khớp.
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Tài liệu tham khảo
Agarwal, M., Agarwal, M. K., Shrivastav, N., Pandey, S., & Gaur, P. (2018). A simple and effective method for preparation of chitosan from chitin. International Journal of Life Sciences Research, 41, 721-1728. https://doi.org/10.21276/ijlssr.2018.4.2.18
Ahmad, K., Zhang, Y., Chen, P., Yang, X., & Hou, H. (2024). Chitosan interaction with stomach mucin layer to enhances gastric retention and mucoadhesive properties. Carbohydrate Polymers, 333, 121926. https://doi.org/10.1016/j.carbpol.2024.121926
Alkhader, E., Billa, N., & Roberts, C. J. (2017). Mucoadhesive chitosan-pectinate nanoparticles for the delivery of curcumin to the colon. AAPS PharmSciTech, 18(4), 1009-1018. https://doi.org/10.1208/s12249-016-0623-y
Arya, N., Chakraborty, S., Dube, N. and Katti, D.S. (2009), Electrospraying: A facile technique for synthesis of chitosan-based micro/nanospheres for drug delivery applications. Journal of Biomedical Materials Research, 88B(1), 17-31.
https://doi.org/10.1002/jbm.b.31085
Bernkop-Schnürch, A., & Dünnhaupt, S. (2012). Chitosan-based drug delivery systems. European Journal of Pharmaceutics and Biopharmaceutics, 81(3), 463-469. https://doi.org/10.1016/j.ejpb.2012.04.007
Cao-Luu, N.-H., Luong, H. V.-T., Pham, D. T., Nguyen-Thi, B.-T., Ngo-Truong, N.-M., Dang, H. G., & Nguyen, T. V. (2025). Development of sustained-release curcumin and piperine co-encapsulated electro-sprayed multilayer chitosan microparticles. Colloid and Polymer Science, 303, 1331-1345.
https://doi.org/10.1007/s00396-025-05418-3
Cao, L. N. H., Nguyen, T. V., Nguyen, N. Q., Nguyen, T. B. T., Luong, H. V. T., & Pham, D. T. (2024). Alginate functionalized chitosan nanoparticles using multilayer co-axial electro-spraying for ovalbumin controlled release via oral delivery. Journal of Drug Delivery Science and Technology, 96, 105733. https://doi.org/10.1016/j.jddst.2024.105733
Cooper, C., Chapurlat, R., Al-Daghri, N., Herrero-Beaumont, G., Bruyère, O., Rannou, F., Roth, R., Uebelhart, D., & Reginster, J. Y. (2019). Safety of Oral Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Osteoarthritis: What Does the Literature Say?. Drugs & Ageing, 36, 15-24.
https://doi.org/10.1007/s40266-019-00660-1
Da Costa, B. R., Pereira, T. V., Saadat, P., Rudnicki, M., Iskander, S. M., Bodmer, N. S., Bobos, P., Gao, L., Kiyomoto, H. D., & Montezuma, T. (2021). Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis. BMJ, 375. https://doi.org/10.1136/bmj.n2321
Elson, L. A., & Morgan, W. T. J. (1933). A colorimetric method for the determination of glucosamine and chondrosamine. Biochemical Journal, 27(6), 1824. https://doi.org/10.1042/bj0271824
Ghaffarian, R., Pérez-Herrero, E., Oh, H., Raghavan, S. R., & Muro, S. (2016). Chitosan–alginate microcapsules provide gastric protection and intestinal release of ICAM-1-targeting nanocarriers, enabling GI targeting in vivo. Advanced Functional Materials, 26(20), 3382–3393.
https://doi.org/10.1002/adfm.201600084
Hạnh, C. L. N., Thanh, L. H. V., Giao, Đ. H., Mai, N. T. N., Lan, T. N. P., & Tâm, M. C. (2023). Nghiên cứu các yếu tố ảnh hưởng đến dung dịch phun điện và quá trình phun điện đồng trục đối với vi hạt berberine@ chitosan/piperine. Tạp chí Khoa học Đại học Cần Thơ, 59(5), 40-48.
https://doi.org/10.22144/ctujos.2023.184
Henrotin, Y., Mobasheri, A., & Marty, M. (2012). Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis? Arthritis research & therapy, 14(1), 201.
https://doi.org/10.1186/ar3657
Hoan, Đ. N., Phú, V. P., Phú, H. Đ., Sinh, P. N., & Sơn, H. M. (2017). Chế tạo hạt nanocapsules Chitosan chứa thuốc Curcumin bằng phương pháp Coaxial electrospraying. Tạp chí Khoa học và Công nghệ Việt Nam, 20(9), 59-64.
Jain, A., & Jain, S. K. (2008). In vitro and cell uptake studies for targeting of ligand anchored nanoparticles for colon tumors. European Journal of Pharmaceutical Sciences, 35(5), 404-416. https://doi.org/10.1016/j.ejps.2008.08.008
Kumar, M. R., Muzzarelli, R. A., Muzzarelli, C., Sashiwa, H., & Domb, A. (2004). Chitosan chemistry and pharmaceutical perspectives. Chemical Reviews, 104(12), 6017-6084. https://doi.org/10.1021/cr030441b
Lang, X., Wang, T., Sun, M., Chen, X., & Liu, Y. (2020). Advances and applications of chitosan-based nanomaterials as oral delivery carriers: A review. International Journal of Biological Macromolecules, 154, 433-445. https://doi.org/10.1016/j.ijbiomac.2020.03.148
Liu, Y.-H., Zhu, X., Zhou, D., Jin, Y., Zhao, C.-Y., Zhang, Z.-R., & Huang, Y. (2011). pH-sensitive and mucoadhesive microspheres for duodenum-specific drug delivery system. Drug development and industrial pharmacy, 37(7), 868-874. https://doi.org/10.3109/03639045.2010.546801
Lu, Y., Huang, J., Yu, G., Cardenas, R., Wei, S., Wujcik, E. K., & Guo, Z. (2016). Coaxial electrospun fibers: applications in drug delivery and tissue engineering. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 8(5), 654-677. https://doi.org/10.1002/wnan.1391
Masarudin, M. J., Cutts, S. M., Evison, B. J., Phillips, D. R., & Pigram, P. J. (2015). Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [14C]-doxorubicin. Nanotechnology, Science and Applications, 8, 67-80.
https://doi.org/10.2147/NSA.S91785
Matalqah, S. M., Aiedeh, K., Mhaidat, N. M., Alzoubi, K. H., Bustanji, Y., & Hamad, I. (2020). Chitosan nanoparticles as a novel drug delivery system: a review article. Current Drug Targets, 21(15), 1613-1624. https://doi.org/10.2174/1389450121666200711172536
Narváez-Muñoz, C., Ryzhakov, P., & Pons-Prats, J. (2021). Determination of the operational parameters for the manufacturing of spherical PVP particles via electrospray. Polymers, 13(4), 529.
https://doi.org/10.3390/polym13040529
Nguyen, H. T.-T., Tran, T. N., Ha, A. C., & Huynh, P. D. (2022). Impact of deacetylation degree on properties of chitosan for formation of electrosprayed nanoparticles. Journal of Nanotechnology, 2022(1), 2288892. https://doi.org/10.1155/2022/2288892
Nguyen, T.-V., Cao-Luu, N.-H., Dang, H.-G., & Luong, H.-V.-T. (2026). Study on chitosan/carrageenan core-shell nanoparticles for oral co-administration of insulin/exenatide enhance insulin secretion in type 2 diabetes. International Journal of Biological Macromolecules, 356, 151537.
https://doi.org/10.1016/j.ijbiomac.2026.151537
Pant, B., Park, M., & Park, S.-J. (2019). Drug delivery applications of core-sheath nanofibers prepared by coaxial electrospinning: A review. Pharmaceutics, 11(7), 305.
https://doi.org/10.3390/pharmaceutics11070305
Persiani, S., Roda, E., Rovati, L., Locatelli, M., Giacovelli, G., & Roda, A. (2005). Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man. Osteoarthritis and Cartilage, 13(12), 1041-1049. https://doi.org/10.1016/j.joca.2005.07.009
Persiani, S., Rotini, R., Trisolino, G., Rovati, L., Locatelli, M., Paganini, D., Antonioli, D., & Roda, A. (2007). Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose. Osteoarthritis and Cartilage, 15(7), 764-772. https://doi.org/10.1016/j.joca.2007.01.019
Prasetyo, Y. A., Rusdiana, T., & Abdassah, M. (2018). Preparation and characterization of glucosamine nanoparticle by ionic gelation method using chitosan and alginate. Indonesian Journal of Pharmaceutics, 1(1), 1-10. https://doi.org/10.24198/idjp.v1i1.13924
Rinaudo, M. (2006). Chitin and chitosan: Properties and applications. Progress in Polymer Science, 31(7), 603-632. https://doi.org/10.1016/j.progpolymsci.2006.06.001
Simon, R., Marks, V., Leeds, A., & Anderson, J. (2011). A comprehensive review of oral glucosamine use and effects on glucose metabolism in normal and diabetic individuals. Diabetes/metabolism research and reviews, 27(1), 14-27.
https://doi.org/10.1002/dmrr.1150
Sun, L., Chen, Y., Zhou, Y., Guo, D., Fan, Y., Guo, F., Zheng, Y., & Chen, W. (2017). Preparation of 5-fluorouracil-loaded chitosan nanoparticles and study of the sustained release in vitro and in vivo. Asian journal of pharmaceutical sciences, 12(5), 418-423. https://doi.org/10.1016/j.ajps.2017.04.002
Wang, Q.-S., Wang, G.-F., Zhou, J., Gao, L.-N., & Cui, Y.-L. (2016). Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis. International Journal of Pharmaceutics, 515(1-2), 176-185. https://doi.org/10.1016/j.ijpharm.2016.10.002
Wu, D., Huang, Y., Gu, Y., & Fan, W. (2013), Efficacies of different preparations of glucosamine for the treatment of osteoarthritis: a meta-analysis of randomised, double-blind, placebo-controlled trials. International journal of clinical practice, 67(6), 585-594. https://doi.org/10.1111/ijcp.12115
Xu, H., Wang, J., Li, B., Yu, K., Tian, J., Wang, D., & Zhang, W. (2021). Effect of spray modes on electrospray cooling heat transfer of ethanol. Applied Thermal Engineering, 189, 116757. https://doi.org/10.1016/j.applthermaleng.2021.116757
Zaeni, A., Safitri, E., Fuadah, B., & Sudiana, I. N. (2017). Microwave-assisted hydrolysis of chitosan from shrimp shell waste for glucosammine hydrochlorid production. Journal of Physics: Conference Series, 846, 012011. https://doi.org/10.1088/1742-6596/846/1/012011
Zhang, L., Huang, J., Si, T., & Xu, R. X. (2012). Coaxial electrospray of microparticles and nanoparticles for biomedical applications. Expert review of medical devices, 9(6), 595-612. https://doi.org/10.1586/erd.12.58
Zhang, S., & Kawakami, K. (2010). One-step preparation of chitosan solid nanoparticles by electrospray deposition. International Journal of Pharmaceutics, 397(1-2), 211-217. https://doi.org/10.1016/j.ijpharm.2010.07.007